Related Experiment Video
Updated: May 30, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
Published on: August 11, 2012
Adverse events after mass azithromycin treatments for trachoma in Ethiopia
Berhan Ayele1, Teshome Gebre, Jenafir I House
1The Carter Center, Addis Ababa, Ethiopia.
Abstract:
During a cluster-randomized clinical trial for trachoma in Ethiopia, two rounds of adverse event surveillance were performed in a random sample of communities after community-wide mass azithromycin treatment. The prevalence of any reported adverse event ranged from 4.9% to 7.0% in children 1-9 years of age and from 17.0% to 18.7% in persons ≥ 10 years of age. Adverse events appeared to cluster by household and perhaps by village. Mass azithromycin distributions were well tolerated in this setting.
Related Concept Videos
Trichomoniasis
Sexually Transmitted Infections
Amebiasis
American Trypanosomiasis
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Antiprotozoal Agents